Interview – Xeltis brings bioabsorbable tech to heart valves
Restorative pulmonary heart valve clinical trial; information for medical professionals
Brabant MedTech Coalition can give Xeltis an extra push forward - Innovation Origins
Xeltis | LinkedIn
Xeltis initiates the first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Innovation Origins
Xeltis (@Xeltis) / Twitter
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Xplore2 Trial Holding - Xplore 2 Trial
Swiss medtech startup Xeltis raises €10.5 million to develop its novel tissue regeneration treatment for heart disease | EU-Startups
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Device and Clinical Trial Update: OneShot (Covidien) | tctmd.com
Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) | Clinical Research Trial Listing ( Multi Vessel Coronary Artery Disease ) ( NCT04545112 )
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient | DAIC
Serial changes of a bioresorbable pulmonary valved conduit implanted in... | Download Scientific Diagram
Xeltis accelerating clinical trial program - Xeltis
News - Xeltis
Initial Clinical Trial of a Novel Pulmonary Valved Conduit - ScienceDirect
Xeltis initiates European first-in-human trial of restorative haemodialysis access graft - Renal Interventions
Xeltis (@Xeltis) / Twitter
EuroPCR 2017: Xeltis' Regenerated Heart Valve Shows Promising Early Preclinical Data :: Medtech Insight
Xeltis AG - Product Pipeline Analysis, 2019 Update
Xeltis BV | BioWorld
